UPC

Universe Pharmaceuticals Inc
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$4.20M
P/E Ratio
EPS
$-8.39
Beta
1.46
52W High
$17.96
52W Low
$2.00
50-Day MA
$3.51
200-Day MA
$3.77
Dividend Yield
Profit Margin
-20.60%
Forward P/E
PEG Ratio

About Universe Pharmaceuticals Inc

Universe Pharmaceuticals INC, a pharmaceutical company, is engaged in the manufacture, marketing, distribution and sale of products derived from traditional Chinese medicine in China.

Official WebsiteUSAFY End: September

Fundamentals

Revenue (TTM)$17.86M
Gross Profit (TTM)$6.30M
EBITDA$-2.40M
Operating Margin-6.77%
Return on Equity-7.23%
Return on Assets-2.66%
Revenue/Share (TTM)$39.17
Book Value$99.64
Price-to-Book0.07
Price-to-Sales (TTM)0.24
EV/Revenue0.0174
EV/EBITDA0.31
Quarterly Earnings Growth (YoY)-82.00%
Quarterly Revenue Growth (YoY)-14.10%
Shares Outstanding631,760
Float487,250
% Insiders11.38%
% Institutions4.45%

Historical Volatility

HV 10-Day
67.08%
HV 20-Day
112.69%
HV 30-Day
104.80%
HV 60-Day
94.36%
HV Rank

Volatility is currently contracting

Latest News

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.

GlobeNewsWire6/26/2026Neutral
Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. today announced a significant and far-reaching victory in the Unified Patent Court (UPC) in Germany, which ruled that Siemens* infringed upon a critical Hologic mammography technology patent in Siemens' latest mammography system. The court imposed a sweeping injunction, immediately prohibiting Siemens from making, offering, placing on the market, using or importing or storing for those purposes its MAMMOMAT B.brilliant systems across Germany, F.

Business Wire6/16/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026